Expert Interview
Discussing the potential of Amgen's Rocatinlimab and Sanofi's Amlitelimab in patients with Atopic Dermatitis
Ticker(s): AMGN, SNYInstitution: Mount Sinai Medical Center
- Assistant Professor of Dermatology at the Icahn School of Medicine and Director of the Adult Dermatology Consultation Service at Mount Sinai Beth Israel.
- Manages 50+ patients per month with atopic dermatitis
- Specializes in medical dermatology, sexually transmitted diseases, genital dermatology and infectious diseases of the skin.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
